tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Chemed reiterates FY25 EPS guidance of $22.00-$22,30, consensus $22.15

This guidance assumes that there will be no Medicare Cap related to the company’s Florida combined program for the government FY26 beginning on October 1, 2025.

Claim 50% Off TipRanks Premium and Invest with Confidence

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1